FLT3 and acute myeloid leukemia: Our findings indicate that IHCH9033 disrupted the DNA repair pathway, leading to the accumulation of DNA damage and consequent cell apoptosis, thereby demonstrating its antileukemic efficacy, even in TKI-resistant FLT3-ITD AML.